Literature DB >> 4084563

Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites.

N Henry, E O Fantine, J Bolard, A Garnier-Suillerot.   

Abstract

The interaction of the antitumor compound adriamycin with negatively charged unilamellar phospholipid vesicles was studied. The negative charges were provided by cardiolipin or phosphatidic acid. By analyzing the changes in the circular dichroism spectrum of adriamycin, we demonstrated the presence of two different spectral patterns corresponding to two different binding sites (I and II) on the vesicles. In site I, the amino sugar of adriamycin is bound to the ionized phosphate of either cardiolipin or phosphatidic acid, and the dihydroxyanthraquinone lies outside the bilayer. In site II, the amino sugar is still bound to the phosphate, but the dihydroxyanthraquinone moiety is embedded in the bilayer. This has been shown by measuring spectroscopically the binding of the aglycon part to an external probe and by measuring the susceptibility of bound adriamycin to reduction by NADH dehydrogenase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4084563     DOI: 10.1021/bi00346a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  11 in total

1.  Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.

Authors:  Kirk D Fowers; Jindřich Kopeček
Journal:  Macromol Biosci       Date:  2012-01-25       Impact factor: 4.979

2.  Correlation between anthracycline structure and human DNA ligase inhibition.

Authors:  G Ciarrocchi; M Lestingi; M Fontana; S Spadari; A Montecucco
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

3.  Intracellular distribution of anthracyclines in drug resistant cells.

Authors:  G Arancia; A Calcabrini; S Meschini; A Molinari
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

4.  Characteristics of the binding of tacrine to acidic phospholipids.

Authors:  J Y Lehtonen; M Rytömaa; P K Kinnunen
Journal:  Biophys J       Date:  1996-05       Impact factor: 4.033

5.  Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.

Authors:  T G Burke; A C Sartorelli; T R Tritton
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 6.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

7.  Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study.

Authors:  C Heywang; M Saint-Pierre Chazalet; C M Masson; J Bolard
Journal:  Biophys J       Date:  1998-11       Impact factor: 4.033

8.  Binding of adriamycin to liposomes as a probe for membrane lateral organization.

Authors:  T Söderlund; A Jutila; P K Kinnunen
Journal:  Biophys J       Date:  1999-02       Impact factor: 4.033

9.  Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex.

Authors:  B B Hasinoff
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

10.  Dye binding assay reveals doxorubicin preference for DNA versus cardiolipin.

Authors:  Colin A Fox; Robert O Ryan
Journal:  Anal Biochem       Date:  2020-02-08       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.